The TNF-α and IL-6-persistent levels that were more elevated than in healthy subjects are probably due to the fact that these cytokines, usually considered proinflammatory mediators in MS pathology, contribute to neuroprotection too. This evidence concerns the gene TNF and myeloid sarcoma.